Pheton Holdings Ltd is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.
企業コードPTHL
会社名Pheton Holdings Ltd
上場日Sep 05, 2024
最高経営責任者「CEO」Mr. Jianfei Zhang
従業員数10
証券種類Ordinary Share
決算期末Sep 05
本社所在地Room 306, NET Building
都市BEIJING
証券取引所NASDAQ Capital Market Consolidated
国China
郵便番号100012
電話番号861084817665
ウェブサイトhttp://www.ftzy.com.cn/ir/index.php
企業コードPTHL
上場日Sep 05, 2024
最高経営責任者「CEO」Mr. Jianfei Zhang
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし